Base Metals Weekly Round-Up: Russia No Concern For Ukraine Iron

What happened in the base metals space this week? Here's a round up of the top stories covered by the...

Top Pharmaceutical News Stories of 2016

2016 saw countless pharmaceutical companies taken to task for price gouging. Close to the end of the year, a related...

Pharmaceutical Outlook 2017: Seeking a Competitive Edge

One thing’s clear: if pharmaceutical companies want to remain profitable, they’ll need to tweak their business strategy in 2017.

Australian Students School Martin Shkreli

Australian students have successfully produced daraprim, the same drug Martin Shkreli deemed worth $750 a pop.

Best Biotech Stocks 2016: The NASDAQ's Top-Performers

We’re counting down 2016’s five top-performing biotech stocks and exploring possible catalysts for their stock movement.

Big Pharma Wins with the Defeat of Prop 61

Another surprising upset came out of this election: the defeat of Proposition 61, or California’s Drug Price Relief Act.

What You Need to Know About Proposition 61

Proposition 61, which California voters decide on today, has major ramifications for the pharmaceutical industry and its investors.